{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:46:25Z","timestamp":1794091585030,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK-111396"],"award-info":[{"award-number":["R01-DK-111396"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22nk0101229"],"award-info":[{"award-number":["JP22nk0101229"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16788"],"award-info":[{"award-number":["22K16788"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["18060798"],"award-info":[{"award-number":["18060798"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.isci.2023.108262","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:41:59Z","timestamp":1697848919000},"page":"108262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Th1\/17 polarization and potential treatment by an anti-interferon-\u03b3 DNA aptamer in Hunner-type interstitial cystitis"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-5640","authenticated-orcid":false,"given":"Yoshiyuki","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimpei","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Kreder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeda","family":"Daichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Owari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunobu","family":"Futami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ushiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.108262_bib1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Homma","year":"2020","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib2","first-page":"34","article-title":"Diagnosis and Treatment of Interstitial Cystitis\/Bladder Pain Syndrome","volume":"208","author":"Clemens","year":"2022","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2023.108262_bib3","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00404-017-4364-2","article-title":"Etiology, pathophysiology and biomarkers of interstitial cystitis\/painful bladder syndrome","volume":"295","author":"Patnaik","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.isci.2023.108262_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/21681805.2020.1730948","article-title":"Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report","volume":"54","author":"Fall","year":"2020","journal-title":"Scand. J. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib5","first-page":"290","article-title":"Molecular Taxonomy of Interstitial Cystitis\/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies","volume":"202","author":"Akiyama","year":"2019","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2023.108262_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143316","article-title":"Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation","volume":"10","author":"Maeda","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2023.108262_bib7","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00192-013-2112-0","article-title":"Local immune response in bladder pain syndrome\/interstitial cystitis ESSIC type 3C","volume":"24","author":"Gamper","year":"2013","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.isci.2023.108262_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep28652","article-title":"Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis","volume":"6","author":"Akiyama","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2023.108262_bib9","first-page":"1206","article-title":"CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis","volume":"183","author":"Ogawa","year":"2010","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2023.108262_bib10","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/j.pain.0000000000000947","article-title":"Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain","volume":"158","author":"Ichihara","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.isci.2023.108262_bib11","first-page":"1564","article-title":"Cytokine expression in patients with bladder pain syndrome\/interstitial cystitis ESSIC type 3C","volume":"192","author":"Logadottir","year":"2014","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2023.108262_bib12","first-page":"841","article-title":"Efficacy of prednisone for severe refractory ulcerative interstitial cystitis","volume":"173","author":"Soucy","year":"2005","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2023.108262_bib13","first-page":"1186","article-title":"Cyclosporine A for refractory interstitial cystitis\/bladder pain syndrome: experience of 3 tertiary centers","volume":"188","author":"Forrest","year":"2012","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2023.108262_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.eururo.2018.07.026","article-title":"A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis\/Bladder Pain Syndrome","volume":"74","author":"Bosch","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eururo.2009.08.020","article-title":"EAU guidelines on chronic pelvic pain","volume":"57","author":"Fall","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.urology.2018.03.037","article-title":"Endoscopic Injection of Low Dose Triamcinolone: A Simple, Minimally Invasive, and Effective Therapy for Interstitial Cystitis With Hunner Lesions","volume":"118","author":"Funaro","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.isci.2023.108262_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/iju.14505","article-title":"Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis\/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study","volume":"28","author":"Yoshimura","year":"2021","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/nau.23431","article-title":"Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis","volume":"37","author":"Niimi","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.isci.2023.108262_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00192-017-3547-5","article-title":"Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder","volume":"29","author":"Furuta","year":"2018","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.isci.2023.108262_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/JU.0000000000002278","article-title":"Overexpression of HIF1alpha in Hunner Lesions of Interstitial Cystitis: Pathophysiological Implications","volume":"207","author":"Akiyama","year":"2022","journal-title":"J. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jcp.55.9.641","article-title":"Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer","volume":"55","author":"Lopez-Beltran","year":"2002","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.isci.2023.108262_bib22","series-title":"Urinary Bladder Pathology","first-page":"7","article-title":"Normal Anatomy and Histology of the Urinary Bladder with Pathologic Correlates","author":"El-Zaatari","year":"2021"},{"key":"10.1016\/j.isci.2023.108262_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/CAD.0000000000000775","article-title":"A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guerin immunotherapy","volume":"30","author":"Poletajew","year":"2019","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.isci.2023.108262_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/rccm.201104-0714OC","article-title":"The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial","volume":"185","author":"Ritz","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2023.108262_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2023.108262_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal","volume":"53","author":"van de Merwe","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(99)80333-1","article-title":"The interstitial cystitis symptom index and problem index","volume":"49","author":"O'Leary","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.isci.2023.108262_bib29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/nau.23365","article-title":"Digital quantitative analysis of mast cell infiltration in interstitial cystitis","volume":"37","author":"Akiyama","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.isci.2023.108262_bib30","article-title":"Decreased expression of STING predicts poor prognosis in patients with gastric cancer","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2023.108262_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cpch.31","article-title":"Evolving Aptamers with Unnatural Base Pairs","volume":"9","author":"Kimoto","year":"2017","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"10.1016\/j.isci.2023.108262_bib32","doi-asserted-by":"crossref","first-page":"F174","DOI":"10.1152\/ajprenal.00290.2020","article-title":"Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: a novel animal model for Hunner-type interstitial cystitis","volume":"320","author":"Akiyama","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.isci.2023.108262_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.178.1.539","article-title":"Urinary bladder epithelium antigen induces CD8+ T\u00a0cell tolerance, activation, and autoimmune response","volume":"178","author":"Liu","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib34","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","article-title":"Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis","volume":"175","author":"Katsifis","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2023.108262_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T\u00a0cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/096120300678828703","article-title":"Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus","volume":"9","author":"Wong","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.isci.2023.108262_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.isci.2023.108262_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2023.108262_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.isci.2023.108262_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.10816","article-title":"Interleukin-17 in rheumatoid arthritis: if T\u00a0cells were to contribute to inflammation and destruction through synergy","volume":"48","author":"Miossec","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.isci.2023.108262_bib41","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.0900576","article-title":"Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells","volume":"183","author":"Bradshaw","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib42","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/path.6040","article-title":"EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis\/bladder pain syndrome with Hunner's lesion","volume":"259","author":"Jhang","year":"2023","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.isci.2023.108262_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/ncpuro0874","article-title":"Interstitial cystitis and systemic autoimmune diseases","volume":"4","author":"van de Merwe","year":"2007","journal-title":"Nat. Clin. Pract. Urol."},{"key":"10.1016\/j.isci.2023.108262_bib45","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri1957","article-title":"Toll-like receptors in systemic autoimmune disease","volume":"6","author":"Marshak-Rothstein","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/ITT.S89795","article-title":"Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments","volume":"5","author":"Duffy","year":"2016","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.isci.2023.108262_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12016-015-8493-8","article-title":"Environmental Basis of Autoimmunity","volume":"50","author":"Floreani","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.autrev.2007.02.013","article-title":"Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings","volume":"7","author":"Ferraccioli","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2023.108262_bib50","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V91.6.1864","article-title":"Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren's syndrome) begin as nonmalignant antigen-selected expansions","volume":"91","author":"Bahler","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.isci.2023.108262_bib51","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/annrheumdis-2012-202861","article-title":"Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity","volume":"73","author":"Doorenspleet","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2023.108262_bib52","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.4049\/jimmunol.171.5.2725","article-title":"Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid","volume":"171","author":"Owens","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib53","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/hep.26232","article-title":"Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis","volume":"57","author":"Maillette de Buy Wenniger","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2023.108262_bib54","first-page":"333","article-title":"Antitissue antibodies in interstitial cystitis","volume":"11","author":"Jokinen","year":"1972","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib55","first-page":"587","article-title":"Autoantibodies in interstitial cystitis","volume":"151","author":"Ochs","year":"1994","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2023.108262_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s001920050075","article-title":"Lower urinary tract symptoms in patients with Sjogren's syndrome and systemic lupus erythematosus","volume":"11","author":"Haarala","year":"2000","journal-title":"Int. UrogynEcol. J. Pelvic Floor Dysfunct."},{"key":"10.1016\/j.isci.2023.108262_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/00365590310008721","article-title":"Intercurrent autoimmune conditions in classic and non-ulcer interstitial cystitis","volume":"37","author":"Peeker","year":"2003","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1016\/j.isci.2023.108262_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.747098","article-title":"Risk of Autoimmune Diseases in Patients With Interstitial Cystitis\/Bladder Pain Syndrome: A Nationwide Population-Based Study in Taiwan","volume":"8","author":"Yueh","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.isci.2023.108262_bib59","first-page":"1434","article-title":"A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group","volume":"163","author":"Propert","year":"2000","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2023.108262_bib60","article-title":"Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis","volume":"4","author":"Akiyama","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2023.108262_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00281-006-0037-0","article-title":"Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies","volume":"28","author":"Baudino","year":"2006","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.isci.2023.108262_bib62","first-page":"123","article-title":"Interferon-gamma and systemic autoimmunity","volume":"16","author":"Pollard","year":"2013","journal-title":"Discov. Med."},{"key":"10.1016\/j.isci.2023.108262_bib63","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/03009740500417791","article-title":"T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB\/W F1 lupus-prone mice is associated with autoantibody levels and nephritis","volume":"35","author":"Enghard","year":"2006","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.isci.2023.108262_bib64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fimmu.2013.00142","article-title":"The Interferon-Signature of Sjogren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases","volume":"4","author":"Nguyen","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib65","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.4049\/jimmunol.1203525","article-title":"Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1","volume":"190","author":"Nickerson","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib66","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.173.3.2134","article-title":"Type I IFN protects against murine lupus","volume":"173","author":"Hron","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib67","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.4049\/jimmunol.1201477","article-title":"Anti-IFN-alpha\/beta receptor antibody treatment ameliorates disease in lupus-predisposed mice","volume":"189","author":"Baccala","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib68","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1084\/jem.166.3.798","article-title":"In\u00a0vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon","volume":"166","author":"Jacob","year":"1987","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2023.108262_bib69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/eji.1830250103","article-title":"Experimental therapy of systemic lupus erythematosus: the treatment of NZB\/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis","volume":"25","author":"Ozmen","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.isci.2023.108262_bib70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1172\/JCI10167","article-title":"Treatment of murine lupus with cDNA encoding IFN-gammaR\/Fc","volume":"106","author":"Lawson","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2023.108262_bib71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nbt.2556","article-title":"Generation of high-affinity DNA aptamers using an expanded genetic alphabet","volume":"31","author":"Kimoto","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2023.108262_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/srep18478","article-title":"Architecture of high-affinity unnatural-base DNA aptamers toward pharmaceutical applications","volume":"5","author":"Matsunaga","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2023.108262_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2023.108262_bib74","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.omtn.2018.11.011","article-title":"Genetic Alphabet Expansion Provides Versatile Specificities and Activities of Unnatural-Base DNA Aptamers Targeting Cancer Cells","volume":"14","author":"Futami","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2023.108262_bib75","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/jid.2012.365","article-title":"Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata","volume":"133","author":"Gilhar","year":"2013","journal-title":"J.\u00a0Invest. Dermatol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223023398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223023398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:39:49Z","timestamp":1762630789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004223023398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2589004223023398"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.108262","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th1\/17 polarization and potential treatment by an anti-interferon-\u03b3 DNA aptamer in Hunner-type interstitial cystitis","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.108262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"108262"}}